Concord, MA – According to filings with the U.S. Securities and Exchange Commission, Cristcot is raising $35,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Operating Officer, Mark Ensign played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cristcot

Cristcot is a global life sciences company headquartered in Massachusetts. The company focuses on unique drug delivery systems, combination products and specialty drug formulations. Core to the company’s mission, is the philosophy of unobtrusive care where by the performance of the products are measured by the impact they have on the lives of patients and caregivers.

To learn more about Cristcot, visit https://www.cristcot.com/

Contact:
Jennifer J. Davagian, President & CEO
https://www.linkedin.com/in/jennifer-davagian-84181832/
978-212-6380

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved